02.03.2015
Enhanced by the great and positive experience in the field of anesthesiology and medical reanimation, MédiS proves once again that it is the main actor in this area by launching his CISATREX® 10mg / 5ml,...
02.03.2015
MédiS philosophy, which becomes a reality, is to by provide patients high quality medicines while ensuring the economy in the management of their disease such as pain. Indeed, MédiS invests again in the management of pain by...
02.03.2015
After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as...
Copyright © 2014 MEDIS | Powered by Web Design